← back to search

Hui Wang

Beijing University of Chinese Medicine · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, and MicroRNA in disease regulation.
h-index
62
citations
14,957
works
427
NIH funding
primary concept
Medicine
email

Recent publications

Wave succession in the pandemic clone of Vibrio parahaemolyticus driven by gene loss.
2026cited by 4position: contributordoi
Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A<sup>+</sup> myeloid cells to promote liver cancer progression.
2025cited by 42position: contributordoi
Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders
Cancer Cell 2025cited by 14position: middledoi
Mesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1/PD-L1 interaction
Journal of Nanobiotechnology 2025cited by 10position: middledoi
The interplay between tissue‐resident microbiome and host proteins by integrated multi‐omics during progression of colorectal adenoma to carcinoma
iMeta 2025cited by 6position: middledoi
Wave succession in the pandemic clone of Vibrio parahaemolyticus driven by gene loss
Nature Ecology & Evolution 2025cited by 2position: middledoi
scGALA advances graph link prediction-based cell alignment for comprehensive data integration and harmonization.
2025cited by 1position: contributordoi
[Application of Digital Nutrition Technologies in Adult Weight Management].
2025cited by 0position: contributordoi
Detecting circulating tumor DNA in archived whole blood samples in patients undergoing treatment for primary cutaneous melanoma
EJC Skin Cancer 2025cited by 0position: middledoi
Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A<sup>+</sup> myeloid cells to promote liver cancer progression
Gut 2024cited by 51position: lastdoi
Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour-intrinsic innate sensing and immunogenicity.
2024cited by 9position: contributordoi
GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma
Oncogene 2024cited by 4position: middledoi
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)
Cancer Cell 2023cited by 208position: middledoi
The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Cancer Cell 2023cited by 190position: lastdoi
Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study
The Lancet Oncology 2023cited by 18position: middledoi
<i>Eucommia</i> Bark/Leaf Extract Improves Lipid Metabolism Disorders by Affecting Intestinal Microbiota and Microbiome-Host Interaction in HFD Mice.
2023cited by 15position: contributordoi
Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity.
2023cited by 12position: contributordoi
Effects of obesity with reduced 25(OH)D levels on bone health in elderly Chinese people: a nationwide cross-sectional study
Frontiers in Immunology 2023cited by 10position: middledoi
Incidence and Predictive Factors of New Onset Postoperative Sacroiliac Joint Pain After Posterior Lumbar Fusion Surgery for Degenerative Lumbar Disease
Journal of Pain Research 2023cited by 3position: middledoi
Enlarged posterior column osteotomy plus intervertebral cage strutting as a exploratory surgery for lumbosacral Nerve bowstring disease: a retrospective retrospective study
Research Square 2023cited by 0position: middledoi
Multi-kingdom microbiota analyses identifybacterial–fungal interactions and biomarkers of colorectal cancer acrosscohorts
Nature Microbiology 2022cited by 296position: lastdoi
Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.
2022cited by 207position: contributordoi
Long-term exposure to genistein inhibits the proliferation of gallbladder cancer by downregulating the MCM complex
Science Bulletin 2022cited by 50position: middledoi
Hounsfield Unit for Assessing Bone Mineral Density Distribution Within Cervical Vertebrae and Its Correlation With the Intervertebral Disc Degeneration
Frontiers in Endocrinology 2022cited by 47position: lastdoi
Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression
Cancer Letters 2022cited by 44position: middledoi
Mycobiome Dysbiosis in Women with Intrauterine Adhesions.
2022cited by 22position: contributordoi
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variants
Cell stem cell 2022cited by 18position: middledoi
Mutagenic Characteristics of Six Heavy Metals in <i>Escherichia coli</i>: The Commonality and Specificity.
2022cited by 10position: contributordoi
Molecular Mechanism of Xingnao Kaiqiao Pill for Perioperative Neurocognitive Disorder and Its Correlation With Immune and Inflammatory Signaling Pathways Based on Network Pharmacology and Molecular Docking
Frontiers in Aging Neuroscience 2022cited by 3position: middledoi
EGFR activation limits the response of liver cancer to lenvatinib
Nature 2021cited by 427position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 15 papers (2019–2026)Wenyuan Ding · Hebei Medical University8 papers (2017–2023)Wenxin Qin · Peking University6 papers (2017–2022)Cun Wang · Shanghai Jiao Tong University5 papers (2017–2022)Ming Yao · Northeast Petroleum University5 papers (2017–2022)Chengtao Yu · Shanghai Cancer Institute4 papers (2018–2022)Haojie Jin · Kunming University of Science and Technology4 papers (2017–2020)Fangyu Zhao · University of Chinese Academy of Sciences4 papers (2017–2020)Jia He · Service de Santé des Armées4 papers (2017–2020)Christopher Heeschen · State Key Laboratory of Oncogene and Related Genes4 papers (2022–2025)Sidong Yang · Hebei Medical University3 papers (2017–2017)Zhuoan Cheng · Soochow University3 papers (2019–2022)Ning‐Ning Liu · Shanghai Jiao Tong University3 papers (2022–2025)Qiaozhu Zuo · Shanghai Jiao Tong University3 papers (2019–2022)Chen Yang · Hunan University of Traditional Chinese Medicine3 papers (2018–2021)Xiaoguang Li · Qilu Hospital of Shandong University3 papers (2023–2024)Jia Fan · China Medical University2 papers (2017–2019)Ruifu Yang · Ministry Of Health2 papers (2025–2026)Lei Ma · Yunnan Provincial Hospital of Traditional Chinese Medicine2 papers (2017–2017)Xuan Deng · Fudan University2 papers (2017–2019)